Mohammad Z, Yudin S, Goldberg B, Serra K, Klegeris A
Rev Neurosci. 2024; 36(1):91-117.
PMID: 39240134
PMC: 11717358.
DOI: 10.1515/revneuro-2024-0081.
Ren X, He J, Li S, Hu H, Kyle M, Kohsaka S
Int J Mol Sci. 2024; 25(16).
PMID: 39201584
PMC: 11354986.
DOI: 10.3390/ijms25168898.
Silva M, Marinho R, Rodrigues Y, Brasil T, Dos Santos P, Silva C
Microorganisms. 2024; 12(4).
PMID: 38674726
PMC: 11051963.
DOI: 10.3390/microorganisms12040782.
Ciechanowska A, Mika J
Int J Mol Sci. 2024; 25(7).
PMID: 38612597
PMC: 11011591.
DOI: 10.3390/ijms25073788.
Song G, Zhang Y, Gao H, Fu Y, Chen Y, Yin Y
Genes (Basel). 2024; 15(2).
PMID: 38397195
PMC: 10888219.
DOI: 10.3390/genes15020205.
The chemokine receptor CCR5: multi-faceted hook for HIV-1.
Faivre N, Verollet C, Dumas F
Retrovirology. 2024; 21(1):2.
PMID: 38263120
PMC: 10807162.
DOI: 10.1186/s12977-024-00634-1.
Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A, Paneerselvam N, Lawson B
Clin Immunol. 2023; 255:109741.
PMID: 37611838
PMC: 10631514.
DOI: 10.1016/j.clim.2023.109741.
A new perspective on HIV: effects of HIV on brain-heart axis.
Shao H, Li S
Front Cardiovasc Med. 2023; 10:1226782.
PMID: 37600062
PMC: 10436320.
DOI: 10.3389/fcvm.2023.1226782.
Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.
Pawlik K, Mika J
Molecules. 2023; 28(15).
PMID: 37570736
PMC: 10421203.
DOI: 10.3390/molecules28155766.
Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model.
Ciechanowska A, Pawlik K, Ciapala K, Mika J
Brain Sci. 2023; 13(4).
PMID: 37190544
PMC: 10136865.
DOI: 10.3390/brainsci13040579.
analysis of dietary polyphenols and their gut microbial metabolites suggest inhibition of SARS-CoV-2 infection, replication, and host inflammatory mediators.
Mezhibovsky E, Hoang S, Szeto S, Roopchand D
J Biomol Struct Dyn. 2023; 41(23):14339-14357.
PMID: 36803516
PMC: 10439978.
DOI: 10.1080/07391102.2023.2180669.
C-C chemokine receptor 5 and acute graft-versus-host disease.
Yuan J, Ren H
Immun Inflamm Dis. 2022; 10(9):e687.
PMID: 36039647
PMC: 9382859.
DOI: 10.1002/iid3.687.
Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.
Anitha A, Narayanan P, Ajayakumar N, Sivakumar K, Kumar K
J Biochem. 2022; 172(3):149-164.
PMID: 35708645
PMC: 9445593.
DOI: 10.1093/jb/mvac052.
Targeting C-C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window After Ischemic Stroke.
Feng Y, Xu Z, Wang Y, Xiong Y, Xie W, He Y
Front Cell Neurosci. 2022; 16:876342.
PMID: 35573839
PMC: 9095921.
DOI: 10.3389/fncel.2022.876342.
Chemokine-Driven Migration of Pro-Inflammatory CD4 T Cells in CNS Autoimmune Disease.
Heng A, Han C, Abbott C, McColl S, Comerford I
Front Immunol. 2022; 13:817473.
PMID: 35250997
PMC: 8889115.
DOI: 10.3389/fimmu.2022.817473.
CCR5 as a Coreceptor for Human Immunodeficiency Virus and Simian Immunodeficiency Viruses: A Prototypic Love-Hate Affair.
Jasinska A, Pandrea I, Apetrei C
Front Immunol. 2022; 13:835994.
PMID: 35154162
PMC: 8829453.
DOI: 10.3389/fimmu.2022.835994.
CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.
Chang X, Wu H, Webb G, Tiwary M, Hughes C, Reed J
Front Immunol. 2021; 12:794638.
PMID: 34868084
PMC: 8640501.
DOI: 10.3389/fimmu.2021.794638.
CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium.
Estevao C, Bowers C, Luo D, Sarker M, Hoeh A, Frudd K
Brain Behav Immun Health. 2021; 18:100370.
PMID: 34755124
PMC: 8560974.
DOI: 10.1016/j.bbih.2021.100370.
Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Ponnan S, Thiruvengadam K, Tellapragada C, Ambikan A, Narayanan A, Kathirvel S
Microbiol Spectr. 2021; 9(2):e0047021.
PMID: 34704803
PMC: 8549735.
DOI: 10.1128/Spectrum.00470-21.
Influence of Genetic Polymorphisms on Clinical Outcomes of Glatiramer Acetate in Multiple Sclerosis Patients.
Zarzuelo-Romero M, Perez-Ramirez C, Cura Y, Carrasco-Campos M, Marangoni-Iglecias L, Ramirez-Tortosa M
J Pers Med. 2021; 11(10).
PMID: 34683173
PMC: 8540092.
DOI: 10.3390/jpm11101032.